In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells by Ito, H. et al.
  
 
 
 
 
Ito, H., Shiwaku, H., Yoshida, C., Homma, H., Luo, H., Chen, X., Fujita, 
K., Musante, L., Fischer, U., Frints, S.G.M., Romano, C., Ikeuchi, Y., 
Shimamura, T., Imoto, S., Miyano, S., Muramatsu, S., Kawauchi, T., 
Hoshino, M., Sudol, M., Arumughan, A., Wanker, E.E., Rich, T., Schwartz, 
C., Matsuzaki, F., Bonni, A., Kalscheuer, V.M., and Okazawa, H. (2015) In 
utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in 
neural stem progenitor cells. Molecular Psychiatry, 20(4), pp. 459-471. 
 
 
Copyright © 2015 Macmillan Publishers Limited. 
 
 
 
 
This work is made available under the Creative Commons Attribution 
NonCommercial-NoDerivs 3.0  License (CC BY-NC-ND 3.0).  
 
Version: Published 
 
 
http://eprints.gla.ac.uk/105585/ 
 
 
 
 
 
 
Deposited on:  1 May 2015. 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of 
Glasgow http://eprints.gla.ac.uk 
OPEN
ORIGINAL ARTICLE
In utero gene therapy rescues microcephaly caused by
Pqbp1-hypofunction in neural stem progenitor cells
H Ito1,17, H Shiwaku1,17, C Yoshida1,17, H Homma1, H Luo1, X Chen1, K Fujita1, L Musante2, U Fischer2, SGM Frints3,4, C Romano5,
Y Ikeuchi6,7, T Shimamura8, S Imoto8, S Miyano8, S-i Muramatsu9, T Kawauchi10, M Hoshino11, M Sudol12, A Arumughan13, EE Wanker13,
T Rich14, C Schwartz15, F Matsuzaki16, A Bonni6,7, VM Kalscheuer2 and H Okazawa1
Human mutations in PQBP1, a molecule involved in transcription and splicing, result in a reduced but architecturally normal brain.
Examination of a conditional Pqbp1-knockout (cKO) mouse with microcephaly failed to reveal either abnormal centrosomes or
mitotic spindles, increased neurogenesis from the neural stem progenitor cell (NSPC) pool or increased cell death in vivo. Instead,
we observed an increase in the length of the cell cycle, particularly for the M phase in NSPCs. Corresponding to the developmental
expression of Pqbp1, the stem cell pool in vivo was decreased at E10 and remained at a low level during neurogenesis (E15) in
Pqbp1-cKO mice. The expression proﬁles of NSPCs derived from the cKO mouse revealed signiﬁcant changes in gene groups that
control the M phase, including anaphase-promoting complex genes, via aberrant transcription and RNA splicing. Exogenous Apc4, a
hub protein in the network of affected genes, recovered the cell cycle, proliferation, and cell phenotypes of NSPCs caused by
Pqbp1-cKO. These data reveal a mechanism of brain size control based on the simple reduction of the NSPC pool by cell cycle time
elongation. Finally, we demonstrated that in utero gene therapy for Pqbp1-cKO mice by intraperitoneal injection of the PQBP1-AAV
vector at E10 successfully rescued microcephaly with preserved cortical structures and improved behavioral abnormalities in Pqbp1-
cKO mice, opening a new strategy for treating this intractable developmental disorder.
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INTRODUCTION
Microcephaly is a group of multiple disorders including PQBP1
gene mutations1–5 and classiﬁed by the presence or absence of
architectural change of cortex. The mechanism of neuronal
production is one of the most critical factors affecting brain size.
According to the classical radial unit hypothesis, brain volume
(cortical thickness × surface area) is determined by neuronal
production from neural stem cells (NSCs) per radial glia unit.6
Neurons in the neocortex are generated over a 6-day neurono-
genesis interval (E11-E17) that comprises 11 cell cycles of NSC self-
renewal and neurogenesis.7 In this model, excessive neurogenesis
during cell division depletes the NSC pool, decreases the vertical
expansion (radial growth) of the pool as well as the ﬁnal
production of neurons, and leads to microcephaly.8 However,
lateral expansion (tangential growth), which should be also related
to brain size, has not been explained well.
The discovery of new subsets in the neural stem progenitor cell
(NSPC) pool has made the story more complex. First, radial glia
were shown to be identical to NSCs and apical progenitor cells
(AP) in the ventricular zone (VZ).9–12 Next, the Tbr2-positive basal
progenitor cell (BP) in the subventricular zone (SVZ) was identiﬁed
to be the primary source of neurons and assumed to regulate
tangential (horizontal) and radial (vertical) expansion of the
cortex.12–15 Moreover, basal radial glia (bRG), Pax6-positive cells
on the basal side of the SVZ, were discovered to be another source
of neuron production.8,16–18 Therefore, the hypothesis was revised
to state that the amounts of BPs/bRGs relative to NSCs/APs
regulate cortical thickness, although the details of the contribution
of the two basal progenitors to corticogenesis remained unknown.
Two recent reports have provided important lines of evidence to
this question. Analysis of Trnp1, a DNA-associated protein whose
exact molecular function is not yet known, revealed that
overexpression of Trnp1 increased the self-renewal of radial glia
and expanded the NSPC pool laterally, while knockdown (KD) of
Trnp1 increased the number of BPs/bRGs and increased the radial
expansion and gyriﬁcation of the cortex.19 Another group
simultaneously reported that the overexpression of Cdk4 and
CyclinD1 (4D) in transgenic mice increased BP/bRG numbers and
gyriﬁcation.20 Importantly, no abnormality was detected in the
cortical layer structure of the folded cortex in 4D transgenic
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mice.20 Therefore, the combination of lateral expansion (tangential
growth) of the NSPC pool, which is affected by neurogenesis ratio,
and vertical expansion (radial growth) to produce BP/bRG and
neurons is now believed to determine the surface area, thickness
and gyration of the cortex.19–21
In this study, we report that cell cycle elongation of NSPCs by
the NSPC-speciﬁc depletion of Pqbp1, which simply delays the
entire process, ﬁnally causes brain downsizing in vivo that mimics
the primary microcephaly (PM)-like phenotype of human patients
with PQBP1-linked intellectual disability (ID). Although neuron and
BP production ratios are unchanged, cell cycle elongation in
NSPCs decreases the AP and BP pools equally, and results in the
proportional reduction of both tangential and radial expansion.
Cell death is not increased in vivo during these processes except in
the extreme case of shRNA-mediated KD. The molecular mechan-
ism, elongation of cell cycle time, is due to aberrant transcription
and RNA splicing of cell cycle-regulating genes. Moreover, we
have developed a new therapy, the peritoneal injection of PQBP1-
adenoassociated virus (AAV) to pregnant mice, that rescues the
microcephaly of the offspring.
MATERIALS AND METHODS
For more detailed information, please refer to ‘Full methods’ in Supple-
mentary Information.
Generation of conditional knockout of murine Pqbp1
To generate the targeting vector, three Pqbp1 genomic fragments were
PCR ampliﬁed from a murine bacterial artiﬁcial chromosome (BAC) library
(ID: RP23-404N15). A 3.6-kb 5′ fragment containing exons 1 and 2 was
inserted upstream of a neomycin resistance cassette ﬂanked by Flp
recognition target sites. A 3.9-kb fragment containing exons 3 to 7 was
inserted between two LoxP sites and a 4.1-kb non-coding fragment was
added 3′, with the diphtheria toxin A gene to prevent random insertion.
After electroporation into ES cells (C57BL/6), and G418 selection (Sigma,
St Louis, MO, USA—200mg/ml), clones were analysed by genomic DNA
PCR using the following primers: fwd, 5′-AATCTTGGAGTTAGTAATGGTGCTT
-3′, and rev, 5′-AATCTCATGTAATTGACGAGACAGAG-3′. Selected ES clones
were corroborated by Southern blot analyses of genomic DNA digested
with EcoRI or EcoRV. Probes for Southern blot analyses were prepared by PCR
from the BAC clone using the following primers (locations given in
Supplementary Fig 2): 5′ probe (408 bp), fwd: AAAGTGAACCTGCATTAG
AGGAAC-3′, rev: TCAGTGAGATACTCTGACTTCCACA; 3′ probe (462 bp), fwd:
GTCAATAAGCATTCAAGGACTCACT, rev: TCAGAATACTCTTGGAACTCCCTTA.
Chimeric mice were generated by injecting the recombinant ES cells into
C57BL/6 blastocysts, subsequently crossed with C57BL/6 mice to generate
the targeted allele. The neomycin resistance cassette was removed by
crossing with CAG-FLPe recombinase transgenic mice.22 The resultant
Pqbp1-ﬂoxed heterozygous female mice were further crossed with Nestin-
Cre transgenic male mice (B6.Cg-Tg (Nes-cre) 1Kln/J; The Jackson
Laboratory, Bar Harbor, ME, USA) and Synapsin1-Cre transgenic male mice
(B6.Cg-Tg (Syn1-Cre)671Jxm/J; The Jackson Laboratory) to generate the
Pqbp1 conditional knockout.
Cumulative labeling
The method for analyzing cell cycle parameters in the neuroepithelium23
was employed with minor modiﬁcations. BrdU (Sigma; 100mg/kg of
body weight) was injected intraperitoneally into pregnant mice at E14.
Cumulative labeling was performed by repeated injections (at 3-h
intervals) into pregnant mice, which were killed 1, 1.5, 2, 3.5, 6.5, 15.5
and 24.5 h after the ﬁrst BrdU injection. Embryonic brains were ﬁxed with
4% paraformaldehyde and parafﬁn embedded. Sections were made at
3mm intervals, deparafﬁnized, rehydrated and then microwaved in 10mM
of citrate buffer, pH 6.0, for 15 min. Antibody incubations were done with
the mouse anti-BrdU antibody (1:200, BD Biosciences, Franklin Lakes, NJ,
USA) and rabbit anti phospho-histone H3 (pH3) antibody, a marker for
M-phase cells (1:500, Millipore, Billerica, MA, USA) at 4 °C overnight.
Secondary antibody incubations were done with Alexaﬂuor-488 or Cy3
conjugates (1:500, Invitrogen, Carlsbad, CA, USA). The ratio of BrdU/pH3-
double-positive cells to pH3-positive cells in the ventricular zone was
calculated at 1, 1.5 and 2 h after a single injection of BrdU to determine the
length of the G2/M phase. A straight-line graph of the labeling index
values (LIs) at 1, 1.5, 2, 3.5 and 6.5 h allowed us to extrapolate to a y-axis
intercept (the LI at 0 h) and calculate the slope. Since the growth fraction
(the ratio of proliferating cells) is nearly 1.0 in the ventricular zone of wild
mice, the LI at 0 h and slope represent the ratio of S-phase to total cell
cycle (Ts/Tc) and the reciprocal of total cell cycle (1/Tc), respectively. Ts and
Tc denote the length of the S-phase and total cell cycle, respectively. From
these values (Ts/Tc and 1/Tc), Ts and Tc were calculated.
Exon array-based analysis of alternative splicing
We analyzed wild type (WT) and PQBP1 conditional knock-out (cKO) mouse
brain samples using Affymetrix GeneChip Mouse Exon 1.0 ST array (exon
array) (http://www.affymetrix.com) to ﬁnd signiﬁcantly changed genes in
terms of potential alternative splicing. The exon array contains over ﬁve
million probes representing about 1.4 million probesets that are designed
based on the genomic regions of known genes and exons to measure both
gene-level and exon-level expression in samples. The sequences of the
probes and the probesets were downloaded at the Affymetrix website
(http://www.affymetrix.com/support/technical/whitepapers/exon_probeset_
trans_clust_whitepaper.pdf). To summarize the probes into the exon-level
probesets, the PLIER algorithm (http://www.affymetrix.com/analysis/index.
affx) was applied to the probe signals of our samples.
Two types of analysis based on statistical hypothesis testing, exon–exon
and variance analyses, were performed on the exon-level probesets to
detect changes in alternative splicing. Before these tests, the signals of
each exon-level probeset in one gene were normalized by their total
signals to eliminate the effects of different numbers of exons among
compared genes. The exon–exon analysis was performed to compare each
exon’s signals between WT and cKO mice to ﬁnd the signiﬁcant change in
exon level that could be induced by the change of alternatively splicing or
transcription. The difference was examined by Student’s t-test based on
the null hypothesis that the means of the two samples are the same. The
variance analysis was performed on exon-level probesets in each gene of
WT and cKO mice to detect changes in relative expression levels among
exons by an F-test for the null hypothesis that these two samples have the
same pattern and the variance.
The smallest P-value was selected as the signiﬁcance level of the gene to
ﬁnd alternatively spliced exons and it was signiﬁcant with P-value o0.05.
Genes showing signiﬁcantly different expression between WT and cKO
mice in exon–exon and/or variance analysis were listed to apply to
PANTHER analysis (http://www.pantherdb.org/). In Panther analysis, stati-
stical overrepresentation test was performed to determine whether the
genes were enriched or deprived for speciﬁc biological processes.
Three groups of signiﬁcantly changed genes, (A) Nestin-cKO-NSC
speciﬁc genes, (B) co-occurrence genes between the NSC and cortex of
Nestin-cKO mice and (C) co-occurrence genes of the three types of cKO
samples, were tested individually by PANTHER analysis to be compared
with all the genes detected in the assay and then pie-charts of protein
function classiﬁcation were formed.
In vivo rescue experiment of Apc4
In utero electroporation and determination of Pial-to-Apical surface area
experiments were performed as described previously.16 Full-length murine
Apc4 cDNA (Genbank accession number NM_024213) was obtained by RT-
PCR using fwd (5′-GGGCTCGAGACCATGGGAATGCTGCGCTTTCCGACCTG
TTT-3′) and rev (5′-GGCGGATCCCTATTATTTGTCGTCATCATCC-3′) primers.
The product was inserted into XhoI/BamHI cut pIRES2-EGFP (Clontech) to
generate pApc4-IRES2-EGFP. For the Apc4 rescue experiments, pAPC4-
IRES2-EGFP or pIRES2-EGFP was electroporated into the ventricular zone of
E13 embryos. Brain tissues of E18 embryos were ﬁxed, embedded in 3%
agarose, and sectioned on the rostral-to-caudal axis as 50-μm-thick
sections using a vibratome. Brain sections were incubated with mouse
anti-green ﬂuorescent protein (GFP) monoclonal antibody (1:500, Millipore)
at 4 °C overnight, followed by treatment with Alexaﬂuor-488 labeled
secondary antibodies. Sections were analyzed with a confocal ﬂuorescence
microscope (Olympus FV10i, Tokyo, Japan) and the ratio of pial-to-apical
surface determined as described previously.8
Gene therapy with PQBP1-AAV vector
The AAV vector plasmids contained an expression cassette, consisting of a
human cytomegalovirus immediate-early promoter (CMV promoter),
followed by cDNA encoding human PQBP1 or human PQBP1-EGFP, and
a simian virus 40 polyadenylation signal sequence (SV40 poly (A)) between
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Figure 1. Microcephaly with normal cortical structures in PQBP1 patients and nestin-Cre Pqbp1-cKO (conditional Pqbp1-knockout) mice.
(a–c) Magnetic resonance imaging of a PQBP1-mutated patient showed normal cortical structures with no periventricular heterotopia:
(a) horizontal, (b) coronal and (c) sagittal sections. (d) Macroscopic images of the brain at the age of 2 months. Male nestin-Cre Pqbp1-cKO
mouse brains (Nes-Cre; XFloxY) were consistently the smallest among the littermates. (e) Pqbp1-cKO mice showed reduction of brain weight at
2 months. The bar graph shows the mean+s.e.m. for each genotype with the number of mice used indicated above. The mean and s.e.m.
values are provided in the text. Asterisks indicate signiﬁcance (Po0.01) in one-way analysis of variance with post hoc Bonferroni test.
(f) Macroscopic images of the brain at the age of 2 months. Male synapsin 1-Cre Pqbp1-cKO mouse brains (synapsin1-Cre; XFloxY) were not
different from the littermates in size. (g) The brain weight of the male synapsin-1-Cre Pqbp1-cKO mouse was not different from that of the
background control. (h) Coronal sections of adult brains of nestin-Cre Pqbp1-cKO mouse and littermates (2 months, at − 1.82mm from the
bregma in background mice). (i) Staining for layer-speciﬁc markers, Cux1, Foxp1 and Tbr1, together with GAD67, shows preservation of
cortical layers in Pqbp1-cKO mice at 2 months.
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the inverted terminal repeats of AAV 3 genome. The recombinant AAV
vectors were produced by transient transfection of HEK293 cells using the
vector plasmid, an AAV2 rep and AAV1 vp expression plasmid, and an
adenoviral helper plasmid, pHelper (Agilent Technologies, Santa Clara, CA,
USA). The recombinant viruses were puriﬁed by isolation from two
sequential CsCl gradients, and the viral titers were determined by qRT-PCR.
For in vivo administration of AAV vectors, C57BL/6J pregnant mice (E10)
were injected with AAV-PQBP1 vector (2.0 × 1011 genome copies) by
intraperitoneal administration.
RESULTS
Human PQBP1 mutations cause PM
First, we deﬁned the characteristics of PQBP1-linked microcephaly
in human patients. Microcephaly is generally deﬁned as an innate
non-progressive small brain sized less than 4 standard deviations
(s.d.); a milder form of microcephaly (less than 3 or 2 s.d.) has been
also reported in some patients. In PQBP1-linked microcephaly, the
brain size ranges from less than 6 s.d. to less than 2 s.d. Although
one PQBP1-linked microcephaly patient with periventricular heter-
otopias (PH) was reported,24 PH is likely to be a rare clinical feature
as it was not observed in an affected sibling with the identical
mutation,24 or in a further 13 microcephalic patients with PQBP1
mutations.25 By magnetic resonance imaging, we conﬁrmed the
presence of well-preserved cortical architecture in two previously
described but unrelated patients with mutated PQBP12,26 (Figures
1a–c). A slight dilation of the ventricles was observed in these
patients having mutated PQBP1, as seen in the autosomal reces-
sive PM (MCPH) cases. All these considerations revealed that
PQBP1-linked microcephaly is quite similar to PM in morphology.
Pqbp1-cKO in NSCs mimics the microcephaly of human patients
Next, we aimed to generate a model of PQBP1-linked micro-
cephaly. Pqbp1 is highly expressed in NSPCs (Sox2-positive AP
cells and RC2-positive radial glia in the VZ and SVZ) and Sox2
transcriptionally regulates Pqbp1 in NSPCs.27 Pqbp1 is also
expressed in differentiated neurons at a lower level.5,27,28 We
therefore generated two types of conditional KO (cKO) mice using
nestin-Cre and synapsin-1-Cre (Figures 1d–g, and Supplementary
Figure 1A). As expected, the expression level of the Pqbp1 protein
was remarkably decreased in the total brain tissue of nestin-Cre
cKO mice, although a faint band was detected due to the non-
neural tissues in the brain (Supplementary Figure 1B). Immuno-
histochemistry of the cortical tissue of synapsin-1-Cre cKO mice
also conﬁrmed the depletion of Pqbp1 in neurons (Supplementary
Figure 1B).
We expected that comparing the two models could distinguish
the effect of Pqbp1-KO from NSPCs from that of Pqbp1-KO after
neuronal differentiation on brain development.29 Male nestin-Cre-
derived Pqbp1-cKO mice had obvious microcephaly. In female
hemizygous cKO mice, the brains were slightly smaller than the
control (Figures 1d and e). Surprisingly, the brain size was not
changed in synapsin-1-Cre derived Pqbp1-cKO mice (Figures 1f
and g). This discrepancy indicated that Pqbp1 function in NSPCs
but not in neurons is responsible for microcephaly. The PM-like
morphological features of the brain indicated that the nestin-Cre
cKO mouse is a good model for PQBP1-linked microcephaly.
At the macroscopic level, brain sections showed normal cortical,
subcortical and brain stem structures in both types of Pqbp1-cKO
mice (Figure 1h). At the histological level, cortical layer structures
were well preserved in both adult (Figure 1i, and Supplementary
Figures 1C and D) and embryonic brains of nestin-Cre Pqbp1-cKO
mice (Supplementary Figures 2A–D). Quantitative analyses revealed
that the layer thickness was decreased in adult (Supplementary
Figures 1C and D) and embryonic brains (Supplementary Figures
2A, C and D). Notably, the thickness of the telencephalon was
already smaller at E10 (Supplementary Figure 2B) when prolifera-
tion of the NSC pool and neurogenesis began.
Asymmetric cell division is not changed in Pqbp1-cKO mice
At the cell level, we checked pathologies in the NSPCs of nestin-
Cre cKO mice. APs facing the ventricular surface of the Pqbp1-cKO
mouse did not show abnormal centrosomes or mitotic spindles
in vivo and in vitro, even though we examined more than 300 APs
(Supplementary Figure 3A). We could not detect detachment of
the centrosome from the mitotic spindle pole as observed in
Cdk5Rap2-mutant cell lines30 or abnormal spindle poles as seen in
ASPM-mutated Drosophila cells.31,32 We also examined the
centrosome and mitotic spindle using primary ﬁbroblasts from
human patients, but did not detect abnormal ﬁndings in these
structures (Supplementary Figure 3B).
We analyzed the mitotic plane angle of APs at E10.5, E14.5 and
E15.5 (Supplementary Figure 3C), because spindle orientation
plays a key role in NSPC differentiation in MCPH. Throughout
these embryonic stages, the mitotic plane angles of cKO mice
were unchanged (Supplementary Figure 3C). Furthermore, we
evaluated the ratio of asymmetric division of APs at E14.5 by
immunohistochemistry with an antibody against N-cadherin
(Supplementary Figure 3D), which serves as a marker for cell fate
through the distribution of the apical membrane to sister cells.
The data showed no change in the percentage of asymmetric cell
division (Supplementary Figure 3D).
Cell cycle time elongates in NSCs of Pqbp1-cKO
At the cellular function level, the cell cycle plays a crucial role in
the tangential and radial expansion of the cortex. The Calegari
group reported previously that in utero electroporation of 4D into
NSPCs, which shortened G1, resulted in enlarged cortical thickness
generated from transfected NSPCs.33 The Huttner group revealed
that G1 is longer in BPs than in Aps, and that S-phase shortening
occurs both in APs and in BPs during commitment to differ-
entiation.34 Studies of MCPH revealed the role of the M phase in
corticogenesis. The causative disease gene products of MCPH1–7
Figure 2. Nestin-Cre Pqbp1-cKO (conditional Pqbp1-knockout) delays the cell cycle but does not affect neurogenesis of neural stem progenitor
cells (NSPCs). (a) The M phase was speciﬁcally elongated in NSPCs of Pqbp1-cKO mice (Nes-Cre; XFloxY) in vivo. Cumulative labeling of NSPCs at
E14 in vivo showed an increase in the total cell cycle length (Tc) of +2.2 h, +12% (upper left panel). G2/M phase time was evaluated using
phosphorylated histone H3 (upper right panel). The middle panels show immunostaining data corresponding to the upper panels. pH3+/BrdU
+ cells were reduced in number in cKO embryos (arrows), indicating elongation of the G2/M phase (middle right panel). The summary of
cumulative labeling and G2/M analyses is shown in the lower table. A signiﬁcant extension of the G2/M phase (+67%) and a slight extension of
G1 (+6%) were observed. The crossing point between the plot line and the x-axis indicates the length of G2 phase (upper right panel). Thus,
the M phase was remarkably elongated while the length of the G2 phase was unchanged in Pqbp1-cKO mice. (b) Neurogenesis from the stem
cell pool was analyzed by co-staining for BrdU and Ki67. At 12 or 72 h after intraperitoneal injection of BrdU, E15 embryonic brains were
analyzed to calculate the numbers of cells after neurogenesis (BrdU+/Ki67− ), cells remaining in the stem cell pool (BrdU+/Ki67+) and non-
labeled stem/progenitor cells (BrdU− /Ki67+). The bar graphs show the relative percentages of the three groups (left graph) and the
neurogenesis percentage of BrdU-labeled cells (right graph). No difference was detected at 24 and 72 h after BrdU injection by the Student’s
t-test or Welch’s t-test. (c) Levels of cell death in the cerebral cortex were evaluated by terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL) staining at E10, E15, E18, P0 and P60 of Pqbp1-cKO mice (Nes-Cre; XFloxY) and nestin-Cre mice (Nes-Cre; XY).
Quantitative analysis of apoptotic cells did not reveal any differences (Student’s t-test).
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(microcephalin, WDR62, Cdk5Rap2, CEP152, ASPM, CENPJ and
STIL)35–41 are localized to the centrosome-spindle pole of
NSPCs38,42,43 and their defective function causes abnormal
centrosome-spindle pole structures.44 A recent report showed
that shRNA-mediated KD of Cdk5Rap2 actually increased neuro-
genesis and the BP pool but reduced the AP pool.45 Intriguingly,
despite large amounts of accumulated data, this series of cell cycle
abnormalities have not yet been sufﬁciently integrated into the
newest hypothesis of corticogenesis.
Hence, we ﬁrst evaluated the cell cycle time of NSPCs in vivo
using the cumulative labeling method.23 The data showed that the
total cell cycle time (Tc) was increased (+2.2 h, +12%) (Figure 2a).
In utero gene therapy rescues microcephaly
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The S phase (Ts) was unaltered compared to the strict control
nestin-Cre XY mice (Figure 2a). The G1 phase was slightly longer
(Figure 2a). However, G1 elongation in the Pqbp1-cKO was minimal
(5.2%) compared to other reports of cell cycle length regulating
brain size.33,34 G2 phase time was not changed (Figure 2a). In
contrast to the G1, S, and G2 phases, the M phase was remarkably
increased (Figure 2a) and the increase in Tc was principally due to
a longer M phase (+1.4 h, +67%). This cell cycle change in Pqbp1-
cKO mice is quite unique among various disease models.
Neurogenesis and apoptosis of NSCs are unchanged in Pqbp1-cKO
M phase arrest or elongation has been linked to increased
neurogenesis.35–43 G1 shortening is related to increased brain size
through the delay of neurogenesis.33 Therefore, we asked whether
neurogenesis from the stem cell pool is altered in Pqbp1-cKO
mouse embryos (Figure 2b). We labeled proliferating cells at the S
phase with BrdU, and examined the brain after an interval to
check whether they exited from the proliferating stem cell pool,
by co-staining with the proliferation marker Ki67. At 24 and 72 h
following labeling, the ratios of the remaining stem cells to
differentiated cells were not largely different between nestin-Cre
XY littermates and Pqbp1-cKO mice (Figure 2b, graphs). In
addition, in utero electroporation of a GFP-expressing vector into
the embryonic brain of the Pqbp1-cKO mouse was performed at
E14 and the embryos were dissected at E16. The neurogenesis
rate, calculated from the ratio of GFP+/ki67− versus total GFP+
cells, was also unaltered (data not shown).
Further, to test the effect of Pqbp1 on neurogenesis, we
performed in vivo KD using short hairpin RNA against Pqbp1
(Pqbp1-shRNA). We generated plasmids expressing Pqbp1-shRNAs
(Supplementary Figure 4A) that successfully suppressed Pqbp1 in
P19 cells, as evidenced by western blot (Supplementary Figure
4B), and dramatically reduced Pqbp1 in NSPCs in vitro or in vivo
(Supplementary Figures 4C–E). In all these cases, Pqbp1 was
decreased to nearly 10%. Pqbp1-KD by in utero electroporation of
Pqbp1-shRNA-ZsGreen into normal mice delayed the exit of
transfected cells from the stem cell layer VZ/SVZ (Supplementary
Figures 5A and B) and delayed their entrance into the
differentiating cell layer IZ (Supplementary Figure 5C). These
results supported the conclusion from Pqbp1-cKO mice that
neurogenesis is not increased in Pqbp1 deﬁciency.
Increased apoptosis of NSPCs is another plausible mechanism
for PM. Indeed, apoptosis was found to be increased in human
microcephaly with preserved brain structure caused by mutations
in polynucleotide kinase 3′-phosphatase, which is essential for
many DNA repair pathways including base-excision repair and non-
homologous end joining.46 However, repeated analyses by terminal
deoxynucleotidyl transferase dUTP nick end labeling staining failed
to demonstrate elevated apoptosis in embryonic (E10–E18),
neonatal (P0) and adult brains of Pqbp1-cKO mice (Figure 2c).
Single-cell volume of neuron is unchanged in Pqbp1-cKO
One may suspect that Pqbp1 deﬁciency causes brain size
reduction by decreasing the single-cell volume of neurons.
However, this is not plausible because synapsin-1-Cre cKO mice
did not show microcephaly, as mentioned previously (Figures 1f
and g). In addition, we examined the space occupied by a single
neuron (cell volume) and the total dendrite length of a neuron
(retrosplenial dysgranular cortex, layer V) in adult nestin-Cre and
synapsin-1-Cre Pqbp1 cKO mice (P90) by two-photon microscopy
(Supplementary Figures 6A and B). The results revealed no
signiﬁcant changes in total neuronal cell volume in nestin-Cre
Pqbp1 cKO mice that had microcephaly, whereas the volume was
decreased in synapsin-1-Cre Pqbp1 cKO mice that did not show
microcephaly (Supplementary Figures 6A and B), indicating that
the single-cell volume does not account for the microcephaly.
Unexpectedly, total dendrite length was not changed either in
nestin-Cre or in synapsin-1-Cre Pqbp1 cKO mice in comparison to
control mice (Supplementary Figures 6A and B). However, the
dendrite diameter tended to be thinner than in the control (data
not shown).
Our previous collaborative study revealed the localization of
Pqbp1 in the cilia of differentiated hippocampal neurons and its
essential role in the maintenance of cilia.28 Given that cilia receive
and transfer environmental signals like Shh to the cell body47 and
that NSPCs also possess cilia, the function of Pqbp1 in cilia might
be related to the proliferation of NSPCs.48 However, we could not
detect any differences in the morphology of cilia on the
ventricular surface of cortex where the cilia of NSPCs are located
(Supplementary Figure 6C), and also could not localize the Pqbp1
protein to the centrosome of NSPCs during mitosis (Supplemen-
tary Figures 7A and B). These results suggested that the role of
PQBP1 in promoting cilia is speciﬁc to differentiated neurons but
not directly linked to the proliferation of NSPCs. The decreased cell
volume of adult neurons in synapsin-1-Cre Pqbp1 cKO mice
(Supplementary Figures 6A and B) was consistent with the change
in the Pqbp1/cilia-derived signal in differentiated neurons.28 The
cell volume change was compensated during development when
Pqbp1 was depleted from NSPCs.
A unique mechanism of microcephaly in Pqbp1-cKO
Collectively, our intensive analyses failed to show the typical
pathomechanisms of PM in Pqbp1-cKO mice, instead of the mor-
phological similarities. The results from this study do not support
the existence of the centrosome-spindle pathology (Supplemen-
tary Figures 3A and B), increased asymmetric cell division
(Supplementary Figures 3C and D), increased neurogenesis from
the stem cell pool (Figure 2b, Supplementary Figures 5A–C),
increased cell death (Figure 2c), or decreased neuronal cell volume
(Supplementary Figure 6A).
The only remaining possibility is the decrease in the stem cell
pool due to elongated cell cycle time. Immunohistochemistry of
Pqbp1-cKO mouse embryos revealed that the size of the stem cell
pool is already small at E10, when neurogenesis has not yet
started (Supplementary Figure 2B). After E11, when neuroepithe-
lial cells start to switch from symmetric proliferative to asymmetric
neurogenic division, delayed cell cycle time (Figure 2a) keeps both
AP and BP stem cell pools equally reduced at E15 (Supplementary
Figures 2C and D), and the reduction of the stem cell pool leads to
a decrease in the number of differentiated neurons (Supplemen-
tary Figure 2A). These results support a simple hypothesis of
microcephaly based on delayed cell proliferation and reduced
expansion of the stem cell pool, which is independent of unequal
changes in the production of neurons or BPs.
Systems biology analyses reveal the molecular mechanism of
microcephaly
Next, we investigated the molecular mechanisms underlying the
cell cycle dysregulation of NSPCs. PQBP1 is a factor coupling
transcription and splicing through two protein-binding motifs, the
WW and C-terminal domains. Currently, mutations of the human
PQBP1 gene are classiﬁed into two types. The ﬁrst category causes
frame shifts that introduce premature stop codons before the
C-terminal domain of PQBP-1.2–4 The second category targets a
conserved amino-acid residue in the WW domain.49,50 These
defects relate to a failure of PQBP1 to interact with its partner
proteins RNA polymerase II51 and WBP11/SIPP152,53 via the WW
domain, and U5-15kD54,55 via the C-terminal domain.
Therefore, mutant PQBP1 is believed to disturb multiple cellular
functions through impairment of RNA splicing and/or transcrip-
tion. Wang et al.56 screened genes affected by aberrant splicing in
mouse embryonic neurons and identiﬁed neural cell adhesion
molecule (NCAM)-140, a splicing isoform of NCAM1 involved in
neurite extension, as a target of PQBP1-mediated aberrant
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splicing. Moreover, the Bonni group recently reported that PQBP1
interacts with the GTPase dynamin2 and affects ciliary morpho-
genesis in postmitotic neurons.28 However, the splicing target of
Pqbp1 in proliferating NSPCs might be different from targets in
non-dividing neurons, and even in neurons splicing might be
inﬂuenced by primary culture and could be different in vivo, where
neurons are supported by multiple circumstantial factors.
Therefore, we rescreened the target genes of PQBP1 in NSPCs
by a combination of an ordinary mRNA gene chip to evaluate
gene expression levels, and an exon array to estimate alternative
splicing patterns. Regarding the gene expression levels, we ﬁrst
summarized data from the ordinary gene chip with primary
cultured NSPCs prepared from nestin-Cre Pqbp1-cKO mice (E15),
and extracted functional gene groups sensitive to Pqbp1
deﬁciency (reactomes) using Gene Set Enrichment Analysis57
(Supplementary Figure 8A and Supplementary Table 1). This
revealed that, in any combination, nearly a half of the reactive
gene groups (reactomes) were related to the M phase (red in
Supplementary Figure 8A and Supplementary Table 1) or another
cell cycle phase (yellow in Supplementary Figure 8A and
Supplementary Table 1), and supporting cell cycle genes were
the main targets of Pqbp1 in NSPCs at the transcriptional level
that are affected by Pqbp1 deﬁciency. In particular, M phase-
related reactomes were signiﬁcantly downregulated (Supplementary
Figure 8B and Supplementary Table 1), consistent with the
elongation of the M phase seen in vivo (Figure 2a). Reactomes in a
dPQBP1 mutant ﬂy58 showed related changes, speciﬁcally in the M
phase (data not shown).
Further, to identify critical genes whose expression was altered
by Pqbp1 deﬁciency in NSPCs, we merged genes selected by Gene
Set Enrichment Analysis with nodes in the protein–protein
interaction network database around PQBP1 (Supplementary
Figure 8C). All the genes showed a densely packed interaction
pattern, as expected. Several genes, including Apc2 (ANAPC2) and
RBMXL1, were linked to more than 25 genes downregulated in
NSPCs from Pqbp1-cKO mice (Supplementary Table 2), suggesting
their role as hubs for executing the role of Pqbp1 in NSPCs. It is of
note that centrosomal proteins were excluded from the network
upon increasing the threshold (Supplementary Figure 8D),
indicating that their role is not so signiﬁcant in the case of
Pqbp1-linked microcephaly.
Interestingly, the protein–protein interaction network revealed
a link from PQBP1 to APC4 via U5-15kD (Supplementary Figure
8E), a spliceosomal component that is transiently incorporated
into the U5 spliceosome when the U5 complex recognizes the
exon–intron junction.59,60 In addition, Apc4 further links to Apc2.
As is well known, Apc2 is the major player in anaphase-promoting
complex/cyclosome, which controls the M phase. Given the
physical interaction between PQBP1 and U5-15kD,54,55 the syn-
chronized dynamics of PQBP1 and U5-15kD in the spliceo-
some59,60 and the genetic interaction between U5-15kD/dim1
and Apc4/lid1,61,62 Apc4 was considered to be the best candidate
for the target gene of PQBP1 in NSPCs, which could transduce the
effect of Pqbp1 deﬁciency into cell cycle elongation.
To identify the target genes of Pqbp1 that were affected by
aberrant splicing under Pqbp1 deﬁciency, we next performed two
independent analyses using the results of exon-array gene chips
(Figure 3a). In the ﬁrst analysis, we normalized all the exon signals
by the total signals in an array, and calculated the ratios of exon
signals to the integrated signal of each gene as described in the
methods. We then compared the ratio of each exon between the
nestin-Cre cKO and the background B6 mice (male) (n= 3) or
between the synapsin-1-Cre cKO mice and B6 mice (male) (n= 3)
in all genes (Supplementary Table 3). In this exon–exon com-
parison, we employed the lowest P-value as the representative of
the gene for ranking when multiple exons were signiﬁcantly
changed in a gene (Supplementary Table 3). Genes ranked at a
high position were considered to be remarkably affected with
respect to their splicing and transcription by Pqbp1 deﬁciency.
In the second approach, we calculated the ‘variance’ of multiple
exon signals from the same gene, and compared it between
background mice and cKO mice (Supplementary Table 4). A
P-value of o0.05 in the F-test was used for judgment that
the ‘variance’ was different between background and cKO mice.
The signiﬁcant change in ‘variance’ was considered to reﬂect the
aberrant splicing. We used the results from these two approaches
to evaluate whether the gene was changed due to aberrant
splicing and/or transcription, as shown schematically (Figure 3a).
Next, we compared the three sets of results. In the ﬁrst ‘exon–
exon comparison’ analysis, among the 39 678 gene transcripts on
the exon array gene chip, 14 712 were affected by Pqbp1
deﬁciency in NSPCs, 13 829 genes were affected in the cortical
tissues of nestin-Cre cKO mice (Figure 3b, left panel), and 19 135
genes were affected in the cortical tissues of synapsin-1-Cre cKO
mice (Figure 3b, left panel). Half of the genes affected in the
NSPCs of nestin-Cre cKO mice (7870 genes) were also affected in
the cortical tissues of both types of cKO mice, while nearly 16% of
them (2386 genes) were unique to nestin-Cre cKO mice (Figure 3b,
left panel; Supplementary Table 5). It is of note that the ratio of
tissue- or model-unique genes was highest in the cortical tissue of
synapsin-1-Cre cKO mice (4526 genes) (Figure 3b, left panel). In
the second analysis, we calculated the variances of exon signals
and compared them between mouse models (Supplementary
Table 4). First, the numbers of changed genes based on the
variance analysis were far smaller than that selected by exon–exon
comparison in all groups (Figure 3b, right panel), suggesting that
Pqbp1 deﬁciency affects gene expression more widely through
transcription than through splicing. The comparison among the
three arrays also showed that the ratios of genes in the intersec-
tion groups were smaller (Figure 3b, right panel; Supplementary
Table 6).
Data from the ordinary gene chip suggested that anaphase-
promoting complex/cyclosome proteins would be a downstream
target of Pqbp1 deﬁciency in NSPCs (Supplementary Figure 8). The
new results from exon arrays consistently supported this idea.
Apc1, which links to Apc4, was signiﬁcantly affected with respect
to splicing in NSPCs and the cortex (Figure 3c, Supplementary
Table 7). Both splicing and transcription affected the expression of
Apc1 judging from the results of ‘exon–exon comparison’ and
‘variance’ analyses. Apc2 expression was also remarkably changed
in NSPC and the cortex, but the effect of splicing on Apc2 did not
seem large (Figures 3a and c, and Supplementary Table 7). On the
other hand, Apc4 was altered speciﬁcally in NSPCs of nestin-Cre
cKO mice (Figure 3c and Supplementary Table 7), suggesting a
relatively large effect of Apc4 on NSPCs and on microcephaly.
Interestingly, Pqbp1 was also affected by itself more strongly
through splicing than through transcription (Figure 3c and
Supplementary Table 7).
With regard to NCAM1, which was previously reported as a
target of aberrant splicing by Pqbp1 KD,56 we conﬁrmed aberrant
splicing of the NCAM1 gene in the cortical tissue of nestin-Cre and
synapsin-1-Cre Pqbp1-cKO mice in exon–exon signal comparison
(Figure 3c and Supplementary Table 7). The discrepancy between
normal dendrite length in vivo (Supplementary Figure 6) and the
aberrant splicing of NCAM1 (Figure 3 and Wang et al.56) suggests
that certain compensatory mechanism(s) recovered the neurite
length in vivo. The aberrant splicing of NCAM1 was not signiﬁcant
in NSPCs under Pqbp1 deﬁciency (Figure 3c and Supplementary
Table 7).
Apc4 is a target gene of Pqbp1 that links to microcephaly
By carrying out reverse transcription polymerase chain reaction
(RT-PCR) with Southern blot, we further tested whether Pqbp1
affected the splicing of Apc4. Pqbp1-KD by veriﬁed shRNA
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(Supplementary Figure 4) increased the amount of intron-
containing pre-mRNAs of Apc4 in primary NSPCs (Supplementary
Figure 9A). In addition, we found that the Pqbp1 protein was
essential for the splicing of Apc4 pre-mRNA because the addition
of anti-PQBP1 antibodies speciﬁcally inhibited the in vitro splicing
of Apc4 but not of crystallin (Supplementary Figure 9B). Nonsense
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RNA decay dependent on Upf1 was expected to be the mech-
anism for the decrease of Apc4 in NSPCs induced by Pqbp1-KD,
(Supplementary Figure 9C). Co-transfection of Upf1-shRNA into
NSPCs increased the number of unspliced introns of Apc4
between exons 22 and 23 or exons 6 and 7 (Supplementary
Figure 9C) and supported nonsense RNA decay.
Figure 4. Apc4 plays a main role in the proliferation and horizontal expansion of neural stem progenitor cells (NSPCs). (a) Proliferation of
NSPCs from E14 nestin-Cre conditional Pqbp1-knockout (cKO) embryos was retarded in primary culture but rescued by transfection of Apc4
(n= 4). **Po0.01 in one-way analysis of variance (ANOVA) with post hoc Tukey’s test. (b) Fluorescence-activated cell sorting analysis showed
G2/M accumulation and a mild increase in the G1 population in NSPCs derived from E14 cKO embryos. Apc4 transfection rescued delayed
proliferation and prevented cyclin B accumulation in NSPCs from cKO embryos. (c) The pial-to-apical surface area ratio reﬂects the
proliferation of in-utero transfected EGFP-positive cells after a deﬁned time period. pApc4-IRES-hrGFPII or pIRES-hrGFPII were electroporated
into the ventricular zone of E13 embryos (nestin-Cre control and cKO mice), and the brains were analyzed at E18. (d) Pial-to-apical ratio was
deduced from 3D reconstruction of the rostral-to-caudal axis serial sections of six embryos in each genotype. The ratio was decreased in
Pqbp1-cKO embryos, reﬂecting the decreased cell cycle times of NSPCs, but it was rescued by Apc4 expression. **Po0.01 or *Po0.05 in one-
way ANOVA with post hoc Tukey’s test.
Figure 3. Analyses of genes affected by aberrant splicing in neurogenesis of neural stem progenitor cells (NSPCs) from nestin-Cre conditional
Pqbp1-knockout (cKO) mice. (a) Representative patterns of exon array signals in a gene are shown. The expected results in the two analyses
(exon–exon and variance) of exon array data and the contribution of splicing/transcription are correlated. (b) Affected genes (Po0.05) were
selected from the exon array results of NSPCs from nestin-Cre cKO mice, the cortex of nestin-Cre cKO mice and the cortex of synapsin-1-Cre
cKO mice by comparison with wild-type mice (B6). The selected genes were further compared among the three genotypes as shown in the
Venn diagram. (c) Results from the two analyses (exon–exon and variance) of exon array data are shown for APC1, APC2, APC4, NCAM (variants
1 and 3) and Pqbp1. When a gene possessed multiple exon probes, the lowest P-value was used as the representative. APC1 and Pqbp1 were
remarkably affected in both analyses in all genotypes. APC4 was signiﬁcantly affected in neural stem cells (NSCs) but not strongly in the
cortex. From the speculation in (a), the effect of transcription was relatively large on APC4 while both transcription and splicing affect APC1
and Pqbp1. NCAM1 (especially variant 3) was affected in the cortex of two types of cKO mice, but the change in NSCs was not so signiﬁcant.
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In addition, we conﬁrmed that human APC4 mRNA is normally
recognized as a splicing target by a spliceosome complex contain-
ing PQBP1, by showing the co-precipitation of PQBP1 and APC4
mRNA in human HEK-293 cells (Supplementary Figures 9D and E).
Blocking nonsense-mediated mRNA decay by cycloheximide after
PQBP1 KD resulted in the preservation of aberrant isoforms
of APC4 pre-mRNA containing intron 23 in human HEK-293
cells (Supplementary Figures 9F–H). The levels of APC4 mRNAs
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measured by quantitative PCR were also reduced in PQBP1-KD
HEK-293 cells (Supplementary Figures 9F and G). Taken together
with NSPC-speciﬁc suppression of Apc4 (Figure 3c), these results
suggested that Apc4 is a speciﬁc target of Pqbp1 deﬁciency in
NSPCs that represses NSPC proliferation through its aberrant
transcription and splicing.
To test whether Apc4 is a major contributor to microcephaly in
Pqbp1 deﬁciency, we performed rescue experiments in vitro and
in vivo. First, we transfected the Apc4 expression vector into NSPCs
from nestin-Cre cKO mice (Figures 4a and b). Overexpression of
Apc4 recovered the decreased Apc4 protein level in NSPCs from
cKO mice and normalized the cell growth speed (Figure 4a).
Consistent with this observation, Apc4 recovered the accumula-
tion of NSPCs at the G2/M phase, as seen with ﬂuorescence-
activated cell sorting (Figure 4b). The effect of Apc4 was also
tested in vivo by in utero electroporation of the APC4 expression
vector into the brains of nestin-Cre cKO mouse embryos (Figures
4c and d). We transfected either a GFP or a GFP-Apc4 plasmid into
control (nestin-Cre) or Pqbp1-cKO (nestin-Cre; Floxed) mouse
embryos at E13 by in utero electroporation, and dissected them at
E18, following a previously reported method to quantify cortical
expansion from NSPCs.33 The ratio of pial-to-apical surface area
was calculated from serial consecutive vibratome sections (50 μm
thick) through the entire rostral-to-caudal axis of E18 brains, as
described.33 The decreased pial-to-apical surface area ratio in
Pqbp1-cKO mice was partially rescued by electroporation of GFP-
Apc4 plasmid but not by GFP in controls (Figures 4c and d). All the
results revealed the cascade from Pqbp1 deﬁciency to micro-
cephaly by cell cycle elongation via Apc4 and related molecules
that were decreased via aberrant transcription and splicing.
PQBP1 rescues microcephaly of nestin-Cre cKO mice
Finally, we performed therapeutic trials for Pqbp1 deﬁciency-
induced microcephaly using AAV expressing human PQBP1
(Figure 5). The viral vector was similar to the one used previously
for human gene therapy of a young girl who suffered from
aromatic L-amino acid decarboxylase deﬁciency63 and for experi-
mental therapy of a mouse model of spinal and bulbar muscular
atrophy (Kennedy’s disease) with miR-196.64 The viral vector was
supplied to mother mice by peritoneal injection at E10, the earliest
time point at which we could conﬁrm pregnancy.
The effect of the AAV vector is known to be sustained for more
than a year.63 Consistent with this, we found that the expression
level of the Pqbp1/PQBP1 proteins, whose sizes are exactly similar
on western blot due to their high homology, was increased to 2.5-
fold at 10 weeks after birth (Figure 5a) though the expression level
was still far lower than that of the background control mice
(Figure 5a). Interestingly, even this limited recovery of Pqbp1/
PQBP1 expression resulted in a signiﬁcant increase in brain weight
(Figure 5b). The macroscopic and microscopic brain architectures
of nestin-Cre cKO mice were normal and proportionally enlarged
(Figures 5c and d). Immunohistological analyses with layer
markers also revealed that the cortical layer structure was well
preserved (Figure 5e), and this conclusion was supported by
quantitative analyses of the thickness of each layer (Figure 5f).
Recovery by PQBP1 supplementation was conﬁrmed not only
for brain morphology but also for behavioral phenotypes (Figures
5g and h). We performed multiple behavior tests with nestin-Cre
and synapsin-1-Cre Pqbp1 cKO mice (Supplementary Figures 10
and 11). Interestingly, while the fear conditioning and rotarod
tests showed similarly abnormal results in both types of cKO mice,
the open ﬁeld, light-dark box, elevated plus maze, and water maze
tests revealed some differences in the results from the different
mouse models (Supplementary Figures 10 and 11). In brief,
synapsin-1-Cre cKO mice were typically careless and insensitive to
fear. On the other hand, the phenotypes of nestin-Cre cKO mice
seemed more complex, which might be a result of developmental
compensation for Pqbp1 deﬁciency in this model. Among such
behavior tests, we observed signiﬁcant recovery of nestin-Cre
Pqbp1 cKO mice in rotarod and fear conditioning tests, which were
abnormal in both types of cKO mice (Supplementary Figures 10
and 11) at 10 weeks after birth, following the intra-peritoneal
injection of PQBP1-AAV to mother mice (Figures 5g and h).
The incomplete recovery in behavioral tests (Supplementary
Figure 10) can be simply explained by the insufﬁcient expression
of the PQBP1/Pqbp1 protein by AAV vector (Figure 5a). However,
it might suggest that brain size recovery is not sufﬁcient for
functional recovery. If this is the case, two explanations are
possible. The ﬁrst one is that the levels of Pqbp1 protein necessary
for architectural recovery and functional recovery might be
different. A higher level of Pqbp1 might be necessary for synapse
dynamism. The second possibility is that the AAV-mediated
delivery of Pqbp1 was too late. There might be a critical period
before E10 for some downstream functions. Further investigations
of these possibilities will be necessary to develop this technique
towards human gene therapy of the ID of PQBP1-mutated
patients.
DISCUSSION
This study provides a unique mechanism of brain size regulation
that depends largely on cell cycle elongation of NSPCs but not on
unequally changed neurogenesis or decreased BP production
ratio. Our ﬁndings might be also discussed from the viewpoint of
the hypothesis that the cell division times of NSPCs determine
neuronal subtypes.65,66 Given that the cell division number of
NSPCs was expected to decrease roughly from 11 to 10 in Pqbp1-
deﬁcient cKO embryos, our ﬁndings might suggest that extrinsic
factors rather than intrinsic determination of NSPCs control the
cortical layer to produce from the NSPC pool at a developmental
time point. However, since the decrease of cell division number is
small, it might also be explained by assuming that cortical layer
formation was compensated in nestin-Cre cKO embryos by
Figure 5. Peritoneal injection of PQBP1-AAV recovers the microcephaly and behaviors of nestin-Cre Pqbp1-cKO (conditional Pqbp1-knockout)
mice. (a) Conﬁrmation of the increase of Pqbp1 protein level in nestin-Cre Pqbp1-cKO mice after injection of PQBP1-AAV vector. Western blot
analysis revealed a 2.5-fold increase. (b) The brain weight of nestin-Cre Pqbp1-cKO mice was recovered by PQBP1-AAV (*Po0.01 in Student’s
t-test). In multiple-group comparison with Tukey’s test, the change was also conﬁrmed (#Po0.05). (c) Macroscopic comparison of brain
morphology between non-treated and AAV-injected male nestin-Cre Pqbp1-cKO mice at 2.5 months (10 weeks). (d) Comparison of coronal
sections of the brain at the exactly same position of non-treated and AAV-injected male nestin-Cre Pqbp1-cKO mice at 2.5 months (10 weeks)
revealed recovery of brain size by the PQBP1-AAV vector. (e) Staining for layer-speciﬁc markers, Cux1, Foxp1, and Tbr1, together with GAD67,
shows the preservation of cortical layers in the rescue of nestin-Cre Pqbp1-cKO mice by the PQBP1-AAV vector at 2.5 months. (f) Quantitative
analysis of the relative thickness of each layer to total thickness of the cortex. No difference was detected between AAV-injected and non-
injected nestin-Cre Pqbp1-cKO mice. (g) The decline of nestin-Cre Pqbp1-cKO mice in the rotarod test was recovered at 3 months after birth by
in utero gene therapy with the PQBP1-AAV vector. **Po0.01 in ANOVA with post hoc Tukey’s test. (h) The decline of nestin-Cre Pqbp1-cKO mice
in fear-conditioned memory was recovered at 3 months by in utero gene therapy with the PQBP1-AAV vector. **Po0.01 or *Po0.05 in ANOVA
with post hoc Tukey’s test.
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overlapped time spans of cortical layers. This is a question for
further investigation.
The results in this study, especially from a newly developed cKO
mouse model that faithfully mimics the magnetic resonance
images of human PQBP1-linked microcephaly, elucidated the
molecular mechanism of Pqbp1-dependent brain size regulation.
Systems biology analyses revealed candidate molecules that are
possibly involved in the mechanism of microcephaly. Especially,
Apc4 is a critical downstream target of Pqbp1 for microcephaly,
and both aberrant splicing and transcription contribute to the
downregulation of Apc4 by Pqbp1.
In the other categories of developmental disorders such as
enzyme deﬁciencies or cystic ﬁbrosis, in utero gene therapy has
been considered.64,67 However, it has not been considered for
normalizing brain tissues or whole brains that were impaired by
genetic defects in microcephaly. Therefore, this is the ﬁrst study to
prove that brain size disorder could be another objective of in
utero gene therapy. This study is just an example, but the method
could be applied to the other microcephalies by targeting each
causative gene. Future advance in genetic diagnosis will help
extremely early initiation of gene therapy especially in the case of
pregnancy of high-risk mothers with the patients in her or
husband’s family.
Technically, gene transfer efﬁciency, virulence, tumorigenesis
and inﬂammation would be the next issues to tackle in order to
adapt this technique to human patients, as shown in the
application of gene therapy for treating cystic ﬁbrosis and other
diseases.68,69 With regard to expression level, this study revealed
that low-level PQBP1 expression was still effective for treating
microcephaly. Regarding the toxicity of AAV, it has been already
used in clinical trials of multiple diseases like cystic ﬁbrosis,
hemophilia B, muscular dystrophy, Parkinson’s disease, Canavan’s
disease and Alzheimer’s disease, and side effects have rarely been
observed.70 Tumorigenesis or inﬂammation has not been reported
thus far. Therefore, a similar approach would be a potential
therapeutic approach to treat human patients with PQBP1-linked
microcephaly if further intensive studies in higher animals can
exclude such side effects.
Naturally, ethical consideration is also essential before clinical
application to human patients. The timing of administration of
AAV vector and the route of gene delivery (intravenous, amniotic
ﬂuid, or cerebrospinal ﬂuid administration; delivery to mother or
embryo) would be the issues in such a case. However, this is the
ﬁrst step for the possibility of gene therapy in microcephaly, and
the issues raised above will be cleared in the future by technical
advances. It would be worth discussing and investigating on it
further.
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